Ramin Farzaneh-far M.d., Facc

Biography

Dr. Ramin Farzaneh-Far, MD, FACC has been the Chief Medical Officer at Ra Pharmaceuticals, Inc. since July 11, 2016. Dr. Farzaneh-Far joined Ra Pharma in 2016. He has expertise in the design, implementation and interpretation of multicenter cardiovascular outcomes trials. He served as Vice President of Medical Research at Akebia Therapeutics, Inc. since September 2015. He served as Director of Cardiovascular Clinical Research at Gilead Sciences, Inc. in Foster City, CA, where he led the clinical development of multiple assets in the cardiovascular therapeutic area. Previously, Dr. Farzaneh-Far held academic faculty positions at the University of California, San Francisco (UCSF) and the University of Texas Southwestern Medical Center in Dallas. Dr. Farzaneh-Far completed his internal medicine residency at Brigham & Women's Hospital in Boston and trained in Cardiovascular Medicine at UCSF. He holds an MD from the University of London, an MAS in Clinical Research from UCSF and both a BA and an MA in Immunology from the University of Cambridge.

Research Interest

Pharmaceutics & Drug Delivery Research